Biggest News Aggregation in the World
📰 Director Beth News

Page 2 - Director Beth News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Director Beth. Real-time updates on events, politics, business and more.

Sagimet Biosciences Inc. Series A (NASDAQ:SGMT) Coverage Initiated at TD Cowen

Equities research analysts at TD Cowen started coverage on shares of Sagimet Biosciences Inc. Series A (NASDAQ:SGMT – Get Free Report) in a report released on Tuesday, Briefing.com reports. The brokerage set an “outperform” rating on the stock. SGMT has been the subject of several other reports. JMP Securities assumed coverage on shares of Sagimet […]
Bethc Seidenberg Piper Sandler Enterprise Associates Securities Exchange Commission Goldman Sachs Group Seriesa Company Profile

TD Cowen Begins Coverage on Sagimet Biosciences Inc. Series A (NASDAQ:SGMT)

Equities researchers at TD Cowen began coverage on shares of Sagimet Biosciences Inc. Series A (NASDAQ:SGMT – Get Free Report) in a report released on Tuesday, Briefing.com reports. The firm set an “outperform” rating on the stock. Several other analysts have also recently commented on SGMT. JMP Securities initiated coverage on shares of Sagimet Biosciences […]
Piper Sandler Bethc Seidenberg Sagimet Biosciences Inc News Ratings For Sagimet Biosciences Inc Seriesa Company Profile Enterprise Associates
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Beth C. Seidenberg Buys 46,875 Shares of Sagimet Biosciences Inc. Series A (NASDAQ:SGMT) Stock

Sagimet Biosciences Inc. Series A (NASDAQ:SGMT – Get Free Report) Director Beth C. Seidenberg acquired 46,875 shares of the company’s stock in a transaction dated Tuesday, July 18th. The shares were bought at an average price of $16.00 per share, for a total transaction of $750,000.00. Following the acquisition, the director now owns 46,875 shares […]
Bethc Seidenberg Sagimet Biosciences Inc News Ratings For Sagimet Biosciences Inc Sagimet Biosciences Get Free Report Director Beth

Acelyrin (NASDAQ:SLRN) Shares Down 1.9%

Acelyrin, Inc. (NASDAQ:SLRN – Free Report) fell 1.9% on Friday . The stock traded as low as $19.46 and last traded at $19.63. 21,262 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 817,256 shares. The stock had previously closed at $20.01. Analyst Upgrades and Downgrades Several research […]
Bethc Seidenberg Hidradenitis Suppurativa Piper Sandler Acelyrin Inc Morgan Stanley Securities Exchange Commission

Acelyrin (NASDAQ:SLRN) Stock Price Down 1.9%

Acelyrin, Inc. (NASDAQ:SLRN – Free Report)’s stock price fell 1.9% during trading on Friday . The company traded as low as $19.46 and last traded at $19.63. 21,262 shares changed hands during mid-day trading, a decline of 97% from the average session volume of 817,256 shares. The stock had previously closed at $20.01. Wall Street […]
Piper Sandler Hidradenitis Suppurativa Bethc Seidenberg Acelyrin Inc Securities Exchange Commission Jefferies Financial Group

Vera Therapeutics (NASDAQ:VERA) Shares Gap Down to $13.35

Vera Therapeutics, Inc. (NASDAQ:VERA – Get Rating)’s stock price gapped down before the market opened on Thursday . The stock had previously closed at $13.35, but opened at $12.94. Vera Therapeutics shares last traded at $12.28, with a volume of 225,405 shares traded. Wall Street Analyst Weigh In VERA has been the topic of several […]
United States Bethc Seidenberg Securities Exchange Commission Barclays Plc Northern Trust Corp American International Group Inc

Vera Therapeutics (NASDAQ:VERA) Stock Price Up 4.4%

Shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Get Rating) rose 4.4% on Wednesday . The stock traded as high as $11.65 and last traded at $11.48. Approximately 75,247 shares were traded during mid-day trading, a decline of 89% from the average daily volume of 680,568 shares. The stock had previously closed at $11.00. Analyst Upgrades […]
United States Bethc Seidenberg Securities Exchange Commission American International Group Inc Jpmorgan Chase Co Vera Therapeutics Company Profile

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science